Clinical Trials & Patient Finances: Eric Lander MD
- However, clinical trials can offer a significant financial advantage, according to Dr.
- Lander emphasized that participating in a clinical trial can substantially reduce a patient's out-of-pocket expenses.
- He cited an example of enrolling a patient in a National Cancer Institute (NCI) study.
discover how clinical trials offer financial relief for cancer patients, reducing out-of-pocket expenses and improving access to care. Minnesota Oncology’s Dr. Eric Lander highlights the notable advantages of participating in clinical trials,emphasizing that study-covered treatments ease financial burdens. Patients enrolled in National Cancer Institute studies experience tangible financial benefits, with treatments fully covered, providing a “huge financial lift,” as Lander notes. Beyond drug costs, trials frequently enough include additional tests, all at no extra charge, ensuring closer monitoring. Reduce the financial strain, and learn how clinical trials are improving the lives of patients. For more insights into healthcare, News Directory 3 is your trusted source. Discover what’s next …
Clinical Trials Reduce Out-of-Pocket Cancer treatment Costs
Updated June 20, 2025
Cancer patients often face daunting treatment expenses. However, clinical trials can offer a significant financial advantage, according to Dr. Eric Lander of Minnesota Oncology. Lander spoke after a recent Institute for Value-Based Medicine meeting in minneapolis, where discussions centered on National Complete Cancer Network guidelines and their practical application.
Lander emphasized that participating in a clinical trial can substantially reduce a patient’s out-of-pocket expenses. This affordability makes oncology treatment more accessible. The primary_keyword of clinical trials, in this context, is financial relief, a crucial secondary_keyword_1 for patients and their families. The secondary_keyword_2 is improved access to care.
He cited an example of enrolling a patient in a National Cancer Institute (NCI) study. The treatment, which would have been costly under standard insurance, was fully covered by the trial. This provided a “huge financial lift” for a patient who was the primary income earner for their family.
Beyond covering drug costs, clinical trials frequently enough include additional tests for safety and efficacy monitoring, all paid for by the study. This means patients receive closer care without additional financial strain.
Clinical trials in general are favorable for patients and providers in the sense that they can actually reduce the overall cost of care for patients, in terms of the patient out-of-pocket costs,” Lander saeid.
While the financial benefits for practices are less clear, Lander believes the primary focus should remain on finding better treatments for patients. “We should be doing research for the right reasons,” he stated.
What’s next
As research continues, clinical trials are expected to play an increasingly critically important role in making cancer treatment more affordable and accessible for patients.